DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

HOECHST

str1

Keep watching this page as it is constantly updated, u can call me +919323115463 or email me/ask info amcrasto@gmail.com
lot of gaps , broken links, will be plugged soon
Hoechst AG (German pronunciation: [ˈhøːçst]) was a German chemicals then life-sciences company that became Aventis Deutschland after its merger with France's Rhône-PoulencS.A. in 1999. With the new company's 2004 merger with Sanofi-Synthélabo, it became a subsidiary of the resulting Sanofi-Aventis pharmaceuticals group

str1
With Dr N J DSOUZA, EX RESEARCH DIRECTOR, HOECHST, ........... Drug Discovery International Conference 2014, Mumbai at Ramada, powai,, mumbai, India on 12 sept 2014
NJ DESOUZA
As a child in Mulund, mumbai, India, in/at Hoechst basic research centre, Dr N J DSOUZA, EX RESEARCH DIRECTOR, HOECHST inspired me , I even went to him to show my thesis..great moments were when they discovered Forskolin
str1
DR BANSI LAL
HEAD RESEARCH, HOECHST RESEARCH CENTRE, MULUND, INDIA

DISCOVERED AT MULUND MUMBAI, HOECHST
bnganguly
Dr B N Ganguly retired from Hoechst and Member Dept of Biotech,delhi.
Vinod Kumar Kansal Image

Vinod Kumar Kansal, President - R & D, Teva API India Ltd

Dr. V. K. Kansal is President of the R&D, TEVA API INDIA LTD, located at Greater Noida.. Before joining TEVA, he was Vice president of R&D, Alembic Limited, Vadodora ( Feb. 2002 to May, 2004), Associate Director, Lupin Laboratory ( 1994-2002) and Group Leader, at ICI and Hoechst Research Center.
Dr. Kansal obtained his Ph.D from CDRI in 1981 under the supervision of Dr. Bhaduri. After finishing his Ph.D, He joined University of Ulster, Colraine, N. Ireland as Research Associate with Prof W. E. Watts and K. C. Knipe and in subsequent year he Moved to University Of East Anglia, Norwich, as Senior Research Associate and pursued his research interest with Prof. R.J.K. Taylor. In 1983, He moved to CNRS, Gif Sur Yvette and worked with Prof. P. Potier at the interface of Chemistry and Biology
In 1986, Dr. Kansal obtained a faculty position in CNRS and moved to Pasteur Institute, Paris, as Charge du Research au CNRS and pursued research on Ant-sense oligonucleotide, synthetic DNA probes and adenylate kinase inhibitors.
Dr. Kansal has published 32 papers and 110 patents to his credit.
Dr. Kansal got TEVA Innovative Highest Award for Innovation in 2005 and 2009 and Twice the Regional Award in 2007 and 2009.
OLD AERIAL SHOT OF HOECHST MULUND
KHINDIPADA
I WAS IN HOECHST MARION ROUSSEL, PROCESS DEVELOPMENT LAB , MULUND, MUMBAI, INDIA, 1992-1997 AND REPORTING TO DR RALPH STAPEL, TECH DIRECTOR, see below in centre
RALPH STAPEL
DR RALPH STAPEL

https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgn_zYQuSCCJLQumLhwW0JpKmxaQUZj0JY156zHcwnB_IZFUHf_eezxyJhq1Eyq9o9wwvEjYsctueI2-j-h41C-FmBu998XdrF2hDaxfT6VuiDnIyw-c-2e7h97SG8QYJSctRrxP1Pjznl3/s500/1414893317_9f6478b4c4%255B1%255D.jpg
The lab was state of art in the country
Photo
ANIL GHOGARE
DR ANIL GHOGARE IN CENTRE........LOT OF HELP FOR ME DURING PHD WORK
BK
DR BALKRISHNA KUKARNI........LOT OF HELP FOR ME DURING PHD WORK

str1

YATENDRA KHANDELWAL

Senior Vice President at Kyowa Kirin International plc
https://www.linkedin.com/in/yatendra-khandelwal-09b33011/


IMG-20190210-WA0002

MYSELF IN HOECHST
ANTHONY hoechst

I LIVED IN HOECHST STAFF QUARTERS MULUND MUMBAI INDIA
M BLDG
hoechst staff qtrs

str1
DR SHIREESH AMBHAIKAR AND DR RAMACHANDRA NAIK

Shireesh Ambhaikar 


Chintamani P Bapat
DR CHINTAMANI BAPAT, SCIENTIST

str1
EX PRINCIPAL SCIENTIST, RESEARCH CENTRE
DR KALPANA JOSHI
https://www.linkedin.com/in/dr-kalpana-joshi-b889a229/


str1

Neelima Khairatkar-Joshi

Chief Consultant at Glenmark Pharmaceuticals Ltd.
https://www.linkedin.com/in/neelima-khairatkar-joshi-27a7345/?originalSubdomain=in
Mayank Shukla
MAYANK SHUKLA, EX PLANT MANAGER

Sudhir Sawant Ph D


 
str1
 
At Hoechst reunion
Satkar grande Thane India
2nd Feb 2019


The former Hoechst AG and today'sIndustriepark Höchst


hoechst dye works


shark
SOME RESEARCHERS

Kirti Aphale

C. SANKAR .

Arunkumar Jain

Shrikant Savanur

Rao Vadlamudi


Dr.Sampada Patvardhan
in.linkedin.com
LinkedIn Dr.Sampada Patvardhan
PUBLICATIONS BY DR SUJATA BHAT, DISCOVERER OF FORSKOLIN
http://www.vazecollege.net/staffprofile/chemadvres/sujatabhat.html
Hoechst Marion Roussel traces its roots to an aniline dye factory begun in 1863 at Höchst am Main, Germany. Venturing into the pharmaceutical industry,
Company History - Sanofi India Ltd.
 
1956- The Company was incorporated as Hoechst Fedco Pharma Pvt. Ltd. on 31st March. The word `Private' was deleted on 19th April, 1961 as the Company was deemed to be Public Limited Company under Section 41-A of the Act.- The Company manufacture bulk drugs, drug intermediates, veterinary formulations and pesticides. They established with financial and technical collaboration of Farbwerke Hoechst AG (now Hoechst AG), West Germany, which is one of the largest chemical and pharmaceutical manufacturing groups in the world.- Under the Licence and Technical Collaboration Agreement dated 11th July, made between Hoechst AG and the Company, the Company was inter alia granted the right to use the word `HOECHST' in its corporate name and the use of the trade marks owned by Hoechst AG in India in respect of various pharmaceutical preparations which would be manufactured and marketed by the Company in India on the terms and conditions mentioned in the said Agreement.
- 10,000 Pref. and 10,000 No. of Equity shares of Rs 100 each issued to promoters. 5000 Pref. and 9,867 No. of Equity shares as Rights in proportion to holdings.
1957
- The Company set up a manufacturing unit at Mulund, for production of basic drugs. In also manufactures intermediates including some of the latest discoveries in the Hoechst Group involving high technology and application of sophisticated modern manufacturing techniques. It also supplies basic drugs to other pharmaceutical companies in India as well as to Europe.
1961
- 28,133 No. of Equity shares issued as Rights.
1967
- 37,800 bonus equity shares issued, propn., 3:5. In June and August, 17,000 No. of Equity shares issued as Rights.
1969
- 57,222 Bonus equity shares issued in the proportion 49:100.
1974
- 1,64,990 Bonus equity shares issued in the proportion 94:100,
1979
- 1,70,256 Bonus equity shares issued in the proportion 1:2.
1982
- The Company set up a manufacturing unit at the Kandla Free Trade Zone to cater to the increasing export market for its products.
- 2,55,384 Bonus equity shares issued in the proportion 1:2.
1984
- The main objects of the public issue was to achieve the voluntary dilution of Hoechst AG's holding in the Company from 50% to 40% and also to provide the requirements of long term resources for capital expenditure to be incurred on account of normal replacement and renovation of capital assets, continuous modernisation and upgradation programmes to achieve efficiency and use of the lates techniques and methods of manufacture to impart high quality and sophistication to the product range.
- 1,19,538 No. of equity shares issued (Prem. of Rs 100 per share) in July, of which 3,800 shares to business associates and 9,600 shares to employees including working directors) were reserved for preferential allotment. The balance 1,78,138 shares offered for public subscription.
1986
- The Land and building water works, plant and machinery of the Company were revalued as on 31st December.
- A new company under the name Hoechst Nepal Pvt. Ltd., was incorporated as a subsidiary of the Company in February in Nepal.
1987
- A new extension of the Haemaccel plant at Mulund and a multi-purpose fine chemicals plant for bulk drugs at Ankleshwar went into commercial production.
- During the year, an industrial licence was obtained for the manufacture of Petoxifylline (TRENTAL), 2 tonnes of Ciclopiroxolamine (BATRAFEN), an antifungal drug and 5.30 lakhs TPA of diagnostic reagents at Ankleshwar.
1988
- Industrial licence was, received for the manufacture of 2 lakh doses of purified chick embroy cell culture vaccine (Human rabies vaccine) known as RABIPUR.
- The Company obtained Central Government approval under the M.R.T.P. Act, 1969 to the establishment of a new undertaking for producing, processing and selling hybrid and high - yielding varieties of seeds.
- The Company issued 2,30,000 - 14% secured redeemable non-convertible debentures of Rs 100 each on private placement basis. These are redeemable at a premium of Rs 5 per debenture on 1st February, 1996.
1989
- The Company re-entered the antifugual market with the introduction of "BATRAFEN" which was an original research product of the Company's collaborators Hoechst AG, West Germany.
- The Company introduced a new insecticide "HOSTATHION". "FLAVOMYCIN", a modern performance promoter for poultry was launched during the year.
- The Pharma formulation plant was commissioned at Ankleshwar in October, liquid injectible automatic filling line was commissioned in Mulund in September.
1990
- New pharma products introduced were TARIVID (a modern oral antibacterial), AVIL retard (sustained release formulation for treatment of allergies) and TABLON (a formulation containing Ibuprofen for the treatment of pain).
- In co-operation with Boots Pharmaceuticals Ltd., a new anti-arthritic drug `FLUROFEN' was introduced.
- A letter of intent were received for BARALGAN Ketone and fomulations, Glybenclamide and formulations, Hostathion technical and formulations, Fenbendazole substance and formulations and Ethion technical and formulations at the Company's works in Ankleshwar. Industrial license was received for manufacture of LASIX retard besides receiving endorsement for manufacture of 13 tonnes of AVIL maleate.
1991
- A new herbicide Klass (Diuron) was introduced during the year. `Butox' and `Tolzan' were the new products introduced for external and internal parasites.
- Industrial licences were received for manufacture of Tonophosphan, Berenil and Fenbendazole and their formulations at Ankleshwar. Letters of intent were received for manufacture of Novalgin tablets and Roxatidine and their formulations at Ankleshwar and Lasiride and Betrafen and their formulations at Mulund.
- The Company revalued its free-hold land, buildings etc and the net surplus of Rs 470,733,868 arising out of its was transferred partly to capital reserve (Rs 149,489,737) and to Revaluation reserve (Rs 321,244,131).
1992
- A modern anti hypertensive `Rene Dil' and latest anti-ulcer drug. `Rotane' were introduced during the year.
- Industrial licences were received for manufacture of Baralgan, Glybenclamide, and their formulations, Roxatidine, Lasiride and formulations and Novalgin tablets at Ankleshwar and Batrafen formulations at Mulund.
- Letters of intent were received for manufacture of Ranipril and formulations, Tabalon tablets and Tarivid tablets at Ankleshwar and cosavil syrup and Streptase formulations at Mulund.
- An additional super centrifuge and auxilliary equipments for the PCEC plant in Ankleshwar were installed and commissioned.
1993
- 19,38,411 No. of Equity shares of Rs 10 each issued at a premium of Rs 60 per share to Hoechst AG to raise its capital from 40% to 51%.
1994
- A product cardare, an ACE inhibitor was introduced. An oral typhoid vaccine called typhonal was also introduced. Candur-R, and antirabies vaccine was launched during the year.
- With effect from 1st April, the Scheme of Arrangement was sanctioned for transfer of the company's agrochemicals division to Hoechst Schering Agrofoo Ltd. In terms of the scheme every shareholder of the Company holding 50 shares, were allotted 10 shares of Rs 10 each of Hoechst Schering Agrofoo Ltd. without any payment.
- Roussel India, Ltd. in which the Company held 4,18,560 No. of equity shares out of 6,27,840 No. of equity shares of Rs 100 each issued is a subsidiary of the Company.
- 115,15,311 shares issued at a bonus shares in proportion 1:1.
1995
- The new products such as ACE inhibitor, Cardace etc. was attributed. The Company launched INSUMAN (human insulin) apart from Floxidin a new broad spectrum antibiotic. Due to the technical difficulties, the Company had to close both foot and mouth disease vaccine and Candur DHL plants.
- Roussel India Ltd., the Company's subsidiary was amalgamated with the Company. Accordingly the name of the Company was changed to Hoechst Marion Roussel Ltd., effective 1st January, 1996.
1996
- `Insuman' an anti-diabetic drug was launched. The production of `Baralgan' was suspended as per the Govt. order.
- The capacity of Rabipur plant at Ankleshwar was expanded from 1.8 million doses to 3.5 million doses per annum to meet the increased demand for the product.
- The Company proposed to set up a joint venture company with Chiron Corporation, USA for manufacture of vaccines of Chiron group. The company proposed to take up 49% of the share capital of the said company.
1997
- The Company proposed to introduce four new products viz. Frisium (anti-epileptic). Amaryl (oran anti-diabetic) cefrom (4th generation cephalosporin) and Targocil (Glycopeptide)
- The German drug multinational Hoechst Roussel is buying out the equity stakes of Colour Chem and two individual entrepreneurs in its Indian joint venture, Hoechst Roussel Vet Private Limited, to convert it into a fully-owned subsidiary.
- Currently, Hoechst Roussel Vet GmbH, along with its subsidiary Hoechst Schering Agrevo Ltd, holds 51 per cent equity in the joint venture.
- Hoechst-Huabei Pharmaceuticals Co. Ltd, is a 50:50 greenfield joint venture between Hoechst Marion Roussel and North china Pharmaceutical Group Corporation (NCPC).
- Hoechst Marion Roussel recently forged a manufacturing joint venture for vaccines with the Chiron group in India.
1998
- Hoechst Marion Roussel (HMR), a 51 per cent subsidiary of Hoechst Marion Roussel, Germany, has a significant presence in pharmaceutical and agrochemicals industries.
- The new joint venture company will manufacture the anti rabies vaccine Rabipur and other vaccines of the Chiron Group.
- HMRL had purchased the 33.33 per cent shareholding of Roussel Laboratories UK in Roussel India, to make the latter a 100 per cent subsidiary of HMRL.
- The company is all set to transfer its animal healthcare business to a joint venture company, in which HMR will have a 49 per cent stake and Chiron Corporation of the US 51 per cent.
- Hoechst proposes to enter into a joint venture with Chiron Corporation of USA for the manufacture of vaccines.
1999
- Hoechst Marion Roussel has launched a voluntary retirement scheme (VRS) at its Mulund factory in Mumbai.
2000
- The Company plans to introduce variants of brands like Allegra and Tavanic in the domestic market.
- The Company has re-designated Ramesh Subrahmanian as deputy managing director of the company with effect from 1st July.
- The Company and Rhone-Poulenc Rorer (India) Ltd. two separate Indian subsidiaries of the French Pharmaceuticals and Chemicals major, Aventis SA, are implementing employee stock option schemes as part of the parent company's worldwide strategy.
- Hoechst Marion Roussel Ltd. will acquire 29,55,608 No. of Equity shares of Rhone-Poulenc Rorer at Rs 15 per share.
- Hoechst Marion Roussel will now be known as Aventis Pharma even as it aims to maintain a leading position within the Indian pharma sector.
2002
-Aventis Pharma Ltd has informed that the Board of Directors of the company has, at its meeting held on October 30, 2002 appointed Mr W Wagner as a Director of the company in the casual vacancy caused by resignation of Mr J Silvestre.
-Bombay High Court sanctions amalgamation of Rhone-Poulenc Rorer with Aventis Pharma Ltd.
-Aventis Pharma increased its sales to Rs.261cr by 16% as against the corresponding period of the previous year.
2003
-Aventis Pharma Ltd has filed a lawsuit against alleging patent infringement on Six Orange Book patent .
-CRISIL withdrew its AAA rating for the Rs.30cr non-convertible Debenture issue of Aventis Pharma Ltd.
-Mr.M.G. Rao and Dr.S Bhattacharya have been appointed as Alternate Directors to Dr.Carlo de Notaristefani and Mr.W.W.Wagner.
-Aventis Pharma has appointed Mr.Ramesh Subramanian, MD as the Vice-president of the Respiratory Sales for North-East and Mid-Atlantic US.
2004
-Aventis Pharma Ltd has informed that the Company had entered into a Joint Venture (JV) Agreement in April 1998 with Chiron Corporation, USA (Chiron) for the manufacture of the anti-rabies vaccine, Rabipur and for the grant of distribution rights in India to the Company for certain Chiron vaccines.
2007
-Aventis Pharma Limited has appointed Mr. Eric Le-Bris as an Additional Director.
-Aventis Pharma Limited has appointed Mr. S.C. Ghoge as Alternate Director to Mr. Eric Le-Bris. Mr. Ghoge being an employee of the Company, has been appointed a Wholetime Director".
2008
-Mumbai: Aventis Pharma has launched insulin drug Lantus in a prefilled disposable pen called Solostar.
2010
- Aventis Pharma Ltd has informed about the following changes which have taken place in the Board of Directors of the Company:
1. Mr. M. Dargentolle, Chief Financial Officer of the Company who was Alternate Director to Mr. O. Charmeil has been appointed a Director of the Company with effect from July 19, 2010.
2. Mr. J. M. Georges, Director, Industrial Pharma Intercontinental of the sanofi-aventis Group and Mr. F. X. Duhalde, Director - Finance & Administration of the sanofi-aventis Group, have been appointed as Additional Directors of the Company with effect from July 29, 2010.
2011
- Aventis Pharma Limited Acquisition of Nutraceutical Business of Universal Medicare Private Limited
- Sanofi India, in association with HealthCare Global Enterprises Ltd, has launched an exclusive Fun Center for pediatric patients in Bangalore, Karnataka
2012
- Sanofi India launches re-usable insulin pen AllStar for Indian patients
- Sanofi appoints Susheel Umesh as Head of Commercial Operations for its Pharmaceutical Operations in India
-Company has changed its name from Aventis Pharma Ltd. to Sanofi India Ltd.
2013
-Sanofi India launches Combiflam Plus. - Sanofi ties up with IDF, PHFI to fight against diabetes among children in India. -"Sanofi partners with PVR Nest for innovative 'Healthy Children, happy children initiative". -"Madhuri Dixit creates signature diabetes dance step for 'What Step Will you Take Today', a Sanofi India initiative". -Sanofi India inks pact with Suzlon Energy for renewable energy.
2014
-Sanofi India - Diabetic Teen from Pune achieves unique feat. -Sanofi partners with Emcure Pharmaceuticals for marketing and distribution of its oncology portfolio in India.
MORE PICS

SHUKLA
MAYANK SHUKLA
Dr. Neelima Deuskar

Dr. Neelima Deuskar

Manjur Momin

Manjur Momin

Dr.Upendra K Jani

Dr.Upendra K Jani

Manoj Kushwaha

Manoj Kushwaha

Krishna Kumar Maheshwari

Krishna Kumar Maheshwari

Swati Bal-Tembe

Former Vice President, Corporate Communications at Piramal Enterprises Limited
SWATI BAL-TEMBE
 
 

Madhukar Tanna


Contacts

Sreedhara Swamy

Consultant in Drug Discovery

Hemant ChaubalHemant Chaubal
Sr. Business Analyst at NuLEAP Technologies PL

Chintamani P BapatChintamani P Bapat
Training in Chemical Process R&D, QbD,
Senior Vice President at Kyowa Kirin International plc
malcolm mascarenhas
Former Head API (Research) at Rusan Pharma Ltd
Dr. Ashok Kumar Gangop[adhyay
Ex-CSO of HIKAL Research Pune

Channaveerayya Hiremath

Sr Manager, Technical Services

Teva Pharmaceutical & Chemical Industries India Pvt. Ltd.


Neelima Khairatkar-Joshi
Neelima Khairatkar-Joshi


T MukhopadhyayT Mukhopadhyay
Advisor (R&D) - Strategy, Innovation & Pr
Discovery Engine at Cipla Ltd
Hazrat Sufi Sayyed Mansoorul hasan shah (RA) Bhandup, khindipada, Mumbai
KHINDIPADA
MAP TODAY
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO …..FOR BLOG HOME CLICK HERE
Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter
Join me on google plus Googleplus

 amcrasto@gmail.com

09b37-misc2b027LIONEL MY SON
He was only in first standard in school when I was hit by a deadly one in a million spine stroke called acute transverse mylitis, it made me 90% paralysed and bound to a wheel chair, Now I keep him as my source of inspiration and helping millions, thanks to millions of my readers who keep me going and help me to keep my son happy
///
SEE.........http://oneorganichemistoneday.blogspot.in/p/hoechst.html

SEE.........https://anthonycrasto.wordpress.com/hoechst/

27 comments:

  1. Interesting blog! I happened to have worked at Hoechst Research before heading to Ph D. Reknidled my memories when saw the lab pictures and that of Drs. De Souza and Bansi Lal

    ReplyDelete
  2. Mindfulness is so significant for individuals. Your insight putting extraordinary exertion towards well being.
    Pharma business consulting
    Pharma and Healthcare business consulting service provider

    ReplyDelete
  3. I am looking for an Business related blog,

    And see your blog and it is really nice and

    have some great information.
    Nice to read your articles.

    Zanac Life Science is a Veterinary Medicine

    Company in IndiaPowermix Gold
    manufacturer of Veterinary product Powermix

    Gold, Liquid Feed Supplement, Liquid Feed

    Supplement of Vitamins for Cattle & Poultry

    Feeding

    ReplyDelete
  4. Nidhi Company Registration Process in Pune, Bangalore India?
    Nidhi Company Registration Process in Pune

    ReplyDelete
  5. Nice it seems to be good post... It will get readers engagement on the article since readers engagement plays an vital role in every blog.. i am expecting more updated posts from your hands.
    Personalized Pen In mumbai

    ReplyDelete
  6. Excellent post. I want to thank you for this informative post. I really appreciate sharing this great post. Keep up your work. Today every business wants a website portfolio. Not only that but they need to market their business via the Internet as well. Zinavo is the most professional and affordable Web Design and Development Company in Bangalore. We provide best Digital Marketing Services for all our Clients. Please visit our website for more information.

    Top Web Design Company in Bangalore
    Website Development Company in Bangalore
    Web Design Agency in Bangalore
    Web Application Company in Bangalore
    Best Digital Marketing Agency in Bangalore
    Social Media Marketing Agency in Bangalore

    ReplyDelete
  7. Dr. Latika Singh is the best Gynecologist in Greater Noida. menstrual disorders treatment in greater noida Those female who are troubled by menstrual disorders and who have other gynecological problems, contact us.

    ReplyDelete
  8. Scothuman Lifesciences is the best ayurvedic pcd franchise Company among our clients despite Third Party Manufacturing Pharma Company with a remarkable affirmation withinside the business community. We acknowledge to serve our clients with all around facilitated conveyance, clean charge decisions, and arranged customer enchanting guidelines those are the means we climb and make our PCD Pharma as a victory organization in India. We at PCD Pharma affirmation on after procedures: -

    Diverse territory of scattering
    Efficient and Affordable Price
    Convenient Multiple Transactions
    Honorable Policies of Business/
    Contact us! +91 9216767741

    ReplyDelete
  9. Absolutely thanks for nourishing the necessary information. I appreciate to u, all are such good information, Thanks. Pharma Manufacturing Company in Lucknow

    ReplyDelete
  10. I read your blog. this blog is superb and very knowledgeable for all readers,thanks for sharing with us
    PCD Pharma Franchise Companies in Pune

    ReplyDelete
  11. I saw you have unique knowledge of Pharma Products. Thanks for sharing such kind of information with us. VIT-Shield | VIT-Shield Medicines | VIT-Shield Ashwagandha 50mg tablets

    ReplyDelete
  12. We are pleased by the details you have posted on your blog, and I have enjoyed reading this information for future reference. Contribute a great deal! Learn something about Ayurved Avail Ayurvedico – Avail Healthcare

    ReplyDelete
  13. Thanks for sharing such amazing information. I hope you keep on sharing such kind of useful information daily. Being one of thePharma Manufacturing Company in Lucknow

    ReplyDelete
  14. This comment has been removed by the author.

    ReplyDelete
  15. Pharma industry is one of the important industries which are play important role in healthcare sectors and also economic sector in country. So Rednirus Mart offer the best list of the top pharma companies dealing in the PCD Pharma .

    ReplyDelete
  16. The information shared here is not only educational but also thought-provoking. want to know about Top Pharma Franchise Company .so you can read by clicking the link.

    ReplyDelete
  17. This information is very helpful. Nice job and keep it up. Join today with the best Pharma Franchise Company in India

    ReplyDelete
  18. Thanks you for sharing this information with us . We, Sonika Life Sciences is among the top pharma franchise company that provides high quality pharmaceutical products.

    ReplyDelete
  19. Thanks for sharing amazing information. it is really helpfull. Critical Care PCD Franchise

    ReplyDelete
  20. This comment has been removed by the author.

    ReplyDelete
  21. Great Blog. Ikon remedies is pharma manufacturer and paediatric product supplier in India, offers a wide range of paediatric products. Our list contains over 1000+ products. Ikon remedies is one of best pharma manufacturer in India Contact us now!

    ReplyDelete
  22. Ikon remedies is pharma manufacturer in India for generic medicine ,offers a wide range of general practitioner supplies. Our list contains over 1000+ products. Contact us now!

    ReplyDelete
  23. I find your blog quite captivating and beneficial. Innovative Pharma is Pharma Manufacturer in India. For the past decade, Innovative Pharmaceuticals has been actively nurturing communities across India and has emerged as one of the leading pharmaceutical companies experiencing significant growth.

    ReplyDelete
  24. Great Blog. Ikon Remedies is at the leading edge of nutraceutical manufacturing in India, providing new health solutions and a diversity of products, committed to quality nutraceutical manufacturer in India.

    ReplyDelete
  25. Nice Information. Innovative Pharma stands as nutraceutical product supplier in India, offering an extensive array of medications at compelling prices. Whether you're exploring trade prospects or pursuing career openings, connect with us without delay for a rewarding collaboration!

    ReplyDelete
  26. The blog is very informative. Thanks for sharing this wonderful article. You can visit best pharmaceutical exporters in India for more details.

    ReplyDelete